Histiocytic Sarcoma and Hemangiosarcoma Update.

摘要: Histiocytic sarcoma (HS) and hemangiosarcoma (HSA) are uncommon aggressive neoplasms that develop much more frequently in dogs than cats. Breed-specific predispositions have been identified for both cancers. The development of novel diagnostics is underway may aid earlier diagnosis. Therapeutic approaches to HS HSA depend on the stage disease include surgery, radiation therapy, chemotherapy. Such interventions improve outcome; however, aside from a small number clinical circumstances, diseases considered largely incurable. Continued efforts toward identification driver mutations subsequent druggable targets lead improvements long-term prognosis.